Final1

0

SIMULTANEOUS STATE OF THE ART LECTURES
7L1 – Purinergic receptors
G. BURNSTOCK (U. K.)
7L2 – Zinc metallopeptidase inhibitors: new developments
P. CORVOL (France)
7L3 – Diabetic vasculopathy
C. F. SANCHEZ FERRER (Spain)
7L4 – The histamine H3 receptor: molecular pharmacology and therapeutic implication
J. C. SCHWARTZ (France)
7L5 – The new pharmacogenetics: clinical implications
F. SJÖQVIST (Sweden)
7L6 – Presynaptic autoreceptors
K. STARKE (Germany)

Scientific content available by clicking on the button    following the title

To get a hard copy of the final programme print it.